Company Filing History:
Years Active: 2025
Title: Raphaël Duivenvoorden: Innovator in Immunology
Introduction
Raphaël Duivenvoorden is a notable inventor based in Gelderland, Netherlands. He has made significant contributions to the field of immunology, particularly in the area of atherosclerosis. His innovative work focuses on targeting the innate immune system to induce long-term tolerance.
Latest Patents
Duivenvoorden holds a patent titled "Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis." This patent includes methods and compositions for inducing long-term tolerance by hybrid nanoparticles. The compositions and formulations he developed comprise hybrid nanoparticles with inherent affinity for innate immune cells.
Career Highlights
Raphaël Duivenvoorden is affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to advance his research. His work has garnered attention for its potential to improve treatments for cardiovascular diseases.
Collaborations
Duivenvoorden collaborates with esteemed colleagues such as Willem Mulder and Jordi Ochando, contributing to a dynamic research environment.
Conclusion
Raphaël Duivenvoorden is a pioneering inventor whose work in immunology is paving the way for innovative treatments in atherosclerosis. His contributions are vital to the ongoing research in this critical area of medicine.